Development of a validated LC-MS/MS method for determination of doxofylline on rat dried blood spots and urine: Application to pharmacokinetics

被引:12
作者
Rao, R. Nageswara [1 ]
Prasad, K. Guru [1 ]
Naidu, Ch Gangu [1 ]
Saida, Shaik [1 ]
Agwane, Sachin B. [2 ]
机构
[1] Discovery Lab, Div Analyt Chem, Hyderabad 500607, Andhra Pradesh, India
[2] Indian Inst Chem Technol, Div Pharmacol, Hyderabad 500607, Andhra Pradesh, India
关键词
Dried blood spots; Rat urine; Hematocrit; LC-MS/MS; Pharmacokinetics; HPLC METHOD; EXTRACTION; SAMPLES;
D O I
10.1016/j.jpba.2013.02.017
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A rapid and highly sensitive liquid chromatography-tandem mass spectrometric (LC-MS/MS) method for determination of doxofylline on rat dried blood spots and urine was developed and validated. The chromatographic separation was achieved on a reverse phase C-18 column (250 mm x 4.6 mm, 5 mu m), using 20 mM ammonium acetate (pH adjusted to 3.5 with trifluoroacetic acid) and acetonitrile (75:25 v/v) as a mobile phase at 25 degrees C LC-MS detection was performed with selective ion monitoring using target ions at m/z 267 and m/z 195 for doxofylline and caffeine used as internal standard respectively. The calibration curve showed a good linearity in the concentration range of 1-5000 ng/mL. The effect of hematocrit on extraction of doxofylline from DBS was evaluated. The mean recoveries of doxofylline from DBS and urine were 93.46 and 89.86% respectively. The intra and inter-day precisions were less than 4.28% in DBS as well as urine. The limit of detection and quantification were 0.24 and 0.84 ng/mL in DBS and 0.28 and 1.00 ng/mL in urine samples respectively. The method was validated as per ICH guidelines and successfully applied to a pharmacokinetic study of doxofylline in rats. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:211 / 216
页数:6
相关论文
共 23 条
[1]   ORAL AND INTRAVENOUS PHARMACOKINETIC PROFILES OF DOXOFYLLINE IN PATIENTS WITH CHRONIC-BRONCHITIS [J].
BOLOGNA, E ;
LAGANA, A ;
TERRACINO, D ;
BOLIGNARI, P ;
BIFFIGNANDI, P .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1990, 18 (04) :282-288
[2]  
CRAVANZOLA C, 1989, DRUG METAB DISPOS, V17, P437
[3]   ADENOSINE RECEPTORS IN THE CENTRAL NERVOUS-SYSTEM - RELATIONSHIP TO THE CENTRAL ACTIONS OF METHYLXANTHINES [J].
DALY, JW ;
BRUNS, RF ;
SNYDER, SH .
LIFE SCIENCES, 1981, 28 (19) :2083-2097
[4]   The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs [J].
Denniff, Philip ;
Spooner, Neil .
BIOANALYSIS, 2010, 2 (08) :1385-1395
[5]   Doxofylline: A new generation xanthine bronchodilator devoid of major cardiovascular adverse effects [J].
Dini, FL ;
Cogo, R .
CURRENT MEDICAL RESEARCH AND OPINION, 2001, 16 (04) :258-268
[6]  
Discenza L, 2012, BIOANALYSIS, V4, P1057, DOI [10.4155/BIO.12.69, 10.4155/bio.12.69]
[7]  
Duan J.L., 1996, CHIN PHARM J, V31, P99
[8]   DOXOFYLLINE EXERTS A PROPHYLACTIC EFFECT AGAINST BRONCHOCONSTRICTION AND PLEURISY INDUCED BY PAF [J].
FRANZONE, JS ;
CIRILLO, R ;
BIFFIGNANDI, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 165 (2-3) :269-277
[9]  
FREDHOLM BB, 1985, ACTA MED SCAND, V217, P149
[10]  
Gannu R, 2007, ACTA CHROMATOGR, V19, P149